LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 55

Search options

  1. Article ; Online: Central role of ubiquitin-specific protease 8 in leptin signaling pathway in pulmonary arterial hypertension.

    Jutant, Etienne-Marie / Chelgham, Mustapha K / Ottaviani, Mina / Thuillet, Raphaël / Le Vely, Benjamin / Humbert, Marc / Guignabert, Christophe / Tu, Ly / Huertas, Alice

    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

    2023  Volume 43, Issue 1, Page(s) 120–133

    Abstract: Background: Leptin receptor (ObR-b) is overexpressed in pulmonary artery smooth muscle cells (PA-SMCs) from patients with pulmonary arterial hypertension (PAH) and is implicated in both mechanisms that contribute to pulmonary vascular remodeling: ... ...

    Abstract Background: Leptin receptor (ObR-b) is overexpressed in pulmonary artery smooth muscle cells (PA-SMCs) from patients with pulmonary arterial hypertension (PAH) and is implicated in both mechanisms that contribute to pulmonary vascular remodeling: hyperproliferation and inflammation. Our aim was to investigate the role of ubiquitin-specific peptidase 8 (USP8) in ObR-b overexpression in PAH.
    Methods: We performed in situ and in vitro experiments in human lung specimens and isolated PA-SMCs combined with 2 different in vivo models in rodents and we generated a mouse with an inducible USP8 deletion specifically in smooth muscles.
    Results: Our results showed an upregulation of USP8 in the smooth muscle layer of distal pulmonary arteries from patients with PAH, and upregulation of USP8 expression in PAH PA-SMCs, compared to controls. USP8 inhibition in PAH PA-SMCs significantly blocked both ObR-b protein expression level at the cell surface as well as ObR-b-dependant intracellular signaling pathway as shown by a significant decrease in pSTAT3 expression. USP8 was required for ObR-b activation in PA-SMCs and its inhibition prevented Ob-mediated cell proliferation through STAT3 pathway. USP8 inhibition by the chemical inhibitor DUBs-IN-2 protected against the development of experimental PH in the 2 established experimental models of PH. Targeting USP8 specifically in smooth muscle cells in a transgenic mouse model also protected against the development of experimental PH.
    Conclusions: Our findings highlight the role of USP8 in ObR-b overexpression and pulmonary vascular remodeling in PAH.
    MeSH term(s) Animals ; Humans ; Mice ; Cell Proliferation/physiology ; Familial Primary Pulmonary Hypertension ; Hypertension, Pulmonary ; Leptin/metabolism ; Myocytes, Smooth Muscle ; Pulmonary Arterial Hypertension/metabolism ; Pulmonary Artery ; Signal Transduction ; Ubiquitin-Specific Proteases/metabolism ; Vascular Remodeling
    Chemical Substances Leptin ; Ubiquitin-Specific Proteases (EC 3.4.19.12) ; Usp8 protein, mouse (EC 3.4.19.12) ; USP8 protein, human (EC 3.4.19.12)
    Language English
    Publishing date 2023-09-11
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1062522-7
    ISSN 1557-3117 ; 1053-2498
    ISSN (online) 1557-3117
    ISSN 1053-2498
    DOI 10.1016/j.healun.2023.09.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Chronic inflammation within the vascular wall in pulmonary arterial hypertension: more than a spectator.

    Huertas, Alice / Tu, Ly / Humbert, Marc / Guignabert, Christophe

    Cardiovascular research

    2019  Volume 116, Issue 5, Page(s) 885–893

    Abstract: This review seeks to provide an update of preclinical findings and available clinical data on the chronic persistent inflammation and its direct role on the pulmonary arterial hypertension (PAH) progression. We reviewed the different mechanisms by which ... ...

    Abstract This review seeks to provide an update of preclinical findings and available clinical data on the chronic persistent inflammation and its direct role on the pulmonary arterial hypertension (PAH) progression. We reviewed the different mechanisms by which the inflammatory and immune pathways contribute to the structural and functional changes occurring in the three vascular compartments: the tunica intima, tunica media, and tunica adventitia. We also discussed how these inflammatory mediator changes may serve as a biomarker of the PAH progression and summarize unanswered questions and opportunities for future studies in this area.
    MeSH term(s) Adventitia/metabolism ; Adventitia/pathology ; Adventitia/physiopathology ; Animals ; Arterial Pressure ; Autoimmunity ; Chronic Disease ; Disease Progression ; Humans ; Inflammation Mediators/metabolism ; Pulmonary Arterial Hypertension/metabolism ; Pulmonary Arterial Hypertension/pathology ; Pulmonary Arterial Hypertension/physiopathology ; Pulmonary Artery/metabolism ; Pulmonary Artery/pathology ; Pulmonary Artery/physiopathology ; Signal Transduction ; Tunica Intima/metabolism ; Tunica Intima/pathology ; Tunica Intima/physiopathology ; Tunica Media/metabolism ; Tunica Media/pathology ; Tunica Media/physiopathology ; Vascular Remodeling ; Vasculitis/metabolism ; Vasculitis/pathology ; Vasculitis/physiopathology
    Chemical Substances Inflammation Mediators
    Language English
    Publishing date 2019-12-05
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 80340-6
    ISSN 1755-3245 ; 0008-6363
    ISSN (online) 1755-3245
    ISSN 0008-6363
    DOI 10.1093/cvr/cvz308
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Phenotypic Diversity of Vascular Smooth Muscle Cells in Pulmonary Arterial Hypertension: Implications for Therapy.

    Lechartier, Benoit / Berrebeh, Nihel / Huertas, Alice / Humbert, Marc / Guignabert, Christophe / Tu, Ly

    Chest

    2021  Volume 161, Issue 1, Page(s) 219–231

    Abstract: Pulmonary arterial hypertension (PAH) is a progressive incurable condition that is characterized by extensive remodeling of the pulmonary circulation, leading to severe right-sided heart failure and death. Similar to other vascular contractile cells, ... ...

    Abstract Pulmonary arterial hypertension (PAH) is a progressive incurable condition that is characterized by extensive remodeling of the pulmonary circulation, leading to severe right-sided heart failure and death. Similar to other vascular contractile cells, pulmonary arterial smooth muscle cells play central roles in physiological and pathologic vascular remodeling because of their remarkable ability to dynamically modulate their phenotype to ensure contractile and synthetic functions. The dysfunction and molecular mechanisms underlying their contribution to the various pulmonary vascular lesions associated with PAH have been a major focus of research. The aim of this review is to describe the medial and nonmedial origins of contractile cells in the pulmonary vascular wall and present evidence of how they contribute to the onset and progression of PAH. We also highlight specific potential target molecules and discuss future directions that are being explored to widen the therapeutic options for the treatment of PAH.
    MeSH term(s) Animals ; Cellular Senescence ; Humans ; Muscle, Smooth, Vascular/cytology ; Muscle, Smooth, Vascular/metabolism ; Muscle, Smooth, Vascular/physiopathology ; Myocytes, Smooth Muscle/metabolism ; Phenotype ; Pulmonary Arterial Hypertension/metabolism ; Pulmonary Arterial Hypertension/physiopathology ; Vascular Remodeling
    Language English
    Publishing date 2021-08-12
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1032552-9
    ISSN 1931-3543 ; 0012-3692
    ISSN (online) 1931-3543
    ISSN 0012-3692
    DOI 10.1016/j.chest.2021.08.040
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Discrete magma injections drive the 2021 La Palma eruption.

    Ubide, Teresa / Márquez, Álvaro / Ancochea, Eumenio / Huertas, María José / Herrera, Raquel / Coello-Bravo, Juan Jesús / Sanz-Mangas, David / Mulder, Jack / MacDonald, Alice / Galindo, Inés

    Science advances

    2023  Volume 9, Issue 27, Page(s) eadg4813

    Abstract: Understanding the drivers of the onset, evolution, and end of eruptions and their impact on eruption style is critical in eruption forecasting and emergency management. The composition of erupted liquids is a key piece of the volcano puzzle, but ... ...

    Abstract Understanding the drivers of the onset, evolution, and end of eruptions and their impact on eruption style is critical in eruption forecasting and emergency management. The composition of erupted liquids is a key piece of the volcano puzzle, but untangling subtle melt variations remains an analytical challenge. Here, we apply rapid, high-resolution matrix geochemical analysis on samples of known eruption date spanning the entire 2021 La Palma eruption. Sr isotope signatures reveal distinct pulses of basanite melt driving the onset, restart, and evolution of the eruption. Elemental variations in matrix and microcrysts track progressive invasion, and draining, of a subcrustal crystal mush. Associated variations in lava flow rate, vent development, seismicity, and SO
    Language English
    Publishing date 2023-07-05
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2810933-8
    ISSN 2375-2548 ; 2375-2548
    ISSN (online) 2375-2548
    ISSN 2375-2548
    DOI 10.1126/sciadv.adg4813
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Erythrocytes are altered in pulmonary arterial hypertension.

    Jutant, Etienne-Marie / Tu, Ly / Thuillet, Raphaël / Picard, Véronique / Guignabert, Christophe / Parent, Florence / Sitbon, Olivier / Humbert, Marc / Savale, Laurent / Huertas, Alice

    The European respiratory journal

    2022  Volume 59, Issue 6

    MeSH term(s) Erythrocytes ; Familial Primary Pulmonary Hypertension ; Humans ; Pulmonary Arterial Hypertension
    Language English
    Publishing date 2022-06-30
    Publishing country England
    Document type Letter
    ZDB-ID 639359-7
    ISSN 1399-3003 ; 0903-1936
    ISSN (online) 1399-3003
    ISSN 0903-1936
    DOI 10.1183/13993003.00506-2022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The Thousand Faces of Leptin in the Lung.

    Jutant, Etienne-Marie / Tu, Ly / Humbert, Marc / Guignabert, Christophe / Huertas, Alice

    Chest

    2020  Volume 159, Issue 1, Page(s) 239–248

    Abstract: Leptin is a pleotropic hormone known to regulate a wide range of systemic functions, from satiety to inflammation. Increasing evidence has shown that leptin and its receptor (ObR) are not only expressed in adipose tissue but also in several organs, ... ...

    Abstract Leptin is a pleotropic hormone known to regulate a wide range of systemic functions, from satiety to inflammation. Increasing evidence has shown that leptin and its receptor (ObR) are not only expressed in adipose tissue but also in several organs, including the lungs. Leptin levels were first believed to be elevated only in the lungs of obese patients, and leptin was suspected to be responsible for obesity-related lung complications. Aside from obesity, leptin displays many faces in the respiratory system, independently of body weight, as this cytokine-like hormone plays important physiological roles, from the embryogenic state to maturation of the lungs and the control of ventilation. The leptin-signaling pathway is also involved in immune modulation and cell proliferation, and its dysregulation can lead to the onset of lung diseases. This review article addresses the thousand faces of leptin and its signaling in the lungs under physiological conditions and in disease.
    MeSH term(s) Humans ; Leptin/physiology ; Lung Diseases/etiology ; Lung Diseases/metabolism ; Lung Diseases/physiopathology
    Chemical Substances Leptin
    Language English
    Publishing date 2020-08-11
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1032552-9
    ISSN 1931-3543 ; 0012-3692
    ISSN (online) 1931-3543
    ISSN 0012-3692
    DOI 10.1016/j.chest.2020.07.075
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: New targets for pulmonary arterial hypertension: going beyond the currently targeted three pathways.

    Huertas, Alice / Tu, Ly / Guignabert, Christophe

    Current opinion in pulmonary medicine

    2017  Volume 23, Issue 5, Page(s) 377–385

    Abstract: Purpose of review: Pulmonary arterial hypertension (PAH) is a hemodynamic state defined by a resting mean pulmonary arterial pressure at or above 25 mmHg with a normal pulmonary capillary wedge pressure, ultimately leading to right heart failure and ... ...

    Abstract Purpose of review: Pulmonary arterial hypertension (PAH) is a hemodynamic state defined by a resting mean pulmonary arterial pressure at or above 25 mmHg with a normal pulmonary capillary wedge pressure, ultimately leading to right heart failure and premature death. Although considerable progress has been made in the development of drug therapies for PAH targeting abnormalities found in the three main pathobiologic pathways (nitric oxide, prostacyclin, and endothelin-1), there is no drug available to specifically stop the progressive cellular accumulation into the pulmonary artery vessel wall. Indeed, this pulmonary vascular remodeling is a key pathological feature in PAH, contributing to the progressive narrowing of the lumen responsible to the functional decline and to the right ventricle hypertrophy and dysfunction.
    Recent findings: Because numerous important discoveries in the PAH pathogenesis have been recently made, our improved understanding of additional pathways in this condition will presumably lead to the development of novel and more powerful therapeutic strategies in the near future.
    Summary: In this review, we highlight some recent biological findings and discuss the opportunities that could lead to the identification of new promising targets in PAH paving the way for future therapeutic strategies.
    Language English
    Publishing date 2017-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1285505-4
    ISSN 1531-6971 ; 1070-5287 ; 1078-1641
    ISSN (online) 1531-6971
    ISSN 1070-5287 ; 1078-1641
    DOI 10.1097/MCP.0000000000000404
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?

    Huertas, Alice / Montani, David / Savale, Laurent / Pichon, Jérémie / Tu, Ly / Parent, Florence / Guignabert, Christophe / Humbert, Marc

    The European respiratory journal

    2020  Volume 56, Issue 1

    MeSH term(s) Betacoronavirus ; COVID-19 ; Coronavirus Infections ; Endothelial Cells ; Humans ; Intensive Care Units ; Pandemics ; Pneumonia, Viral/epidemiology ; SARS-CoV-2 ; Venous Thromboembolism
    Keywords covid19
    Language English
    Publishing date 2020-07-30
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 639359-7
    ISSN 1399-3003 ; 0903-1936
    ISSN (online) 1399-3003
    ISSN 0903-1936
    DOI 10.1183/13993003.01634-2020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Loss of cAbl Tyrosine Kinase in Pulmonary Arterial Hypertension Causes Dysfunction of Vascular Endothelial Cells.

    Le Vely, Benjamin / Phan, Carole / Berrebeh, Nihel / Thuillet, Raphaël / Ottaviani, Mina / Chelgham, Mustapha Kamel / Chaumais, Marie-Camille / Amazit, Larbi / Humbert, Marc / Huertas, Alice / Guignabert, Christophe / Tu, Ly

    American journal of respiratory cell and molecular biology

    2022  Volume 67, Issue 2, Page(s) 215–226

    Abstract: Pulmonary arterial hypertension (PAH) is a progressive and fatal disease characterized by the dysfunction of pulmonary endothelial cells (ECs) and obstructive vascular remodeling. cAbl (non-receptor tyrosine kinase c-Abelson) plays central roles in ... ...

    Abstract Pulmonary arterial hypertension (PAH) is a progressive and fatal disease characterized by the dysfunction of pulmonary endothelial cells (ECs) and obstructive vascular remodeling. cAbl (non-receptor tyrosine kinase c-Abelson) plays central roles in regulating cell-cycle arrest, apoptosis, and senescence after cellular stress. We hypothesized that cAbl is downactivated in experimental and human PAH, thus leading to reduced DNA integrity and angiogenic capacity of pulmonary ECs from patients with PAH (PAH-ECs). We found cAbl and phosphorylated cAbl concentrations to be lower in the endothelium of remodeled pulmonary vessels in the lungs of patients with PAH than in control subjects. Similar observations were obtained for the lungs of Sugen + hypoxia and monocrotaline rats with established pulmonary hypertension. These
    MeSH term(s) Animals ; Disease Models, Animal ; Endothelial Cells/metabolism ; Familial Primary Pulmonary Hypertension/metabolism ; Humans ; Monocrotaline ; Protein-Tyrosine Kinases/metabolism ; Pulmonary Arterial Hypertension ; Pulmonary Artery/metabolism ; Rats
    Chemical Substances Monocrotaline (73077K8HYV) ; Protein-Tyrosine Kinases (EC 2.7.10.1)
    Language English
    Publishing date 2022-05-12
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1025960-0
    ISSN 1535-4989 ; 1044-1549
    ISSN (online) 1535-4989
    ISSN 1044-1549
    DOI 10.1165/rcmb.2021-0332OC
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: COPD: a multifactorial systemic disease.

    Huertas, Alice / Palange, Paolo

    Therapeutic advances in respiratory disease

    2011  Volume 5, Issue 3, Page(s) 217–224

    Abstract: Chronic obstructive pulmonary disease (COPD) has traditionally been considered a disease of the lungs secondary to cigarette smoking and characterized by airflow obstruction due to abnormalities of both airway (bronchitis) and lung parenchyma (emphysema). ...

    Abstract Chronic obstructive pulmonary disease (COPD) has traditionally been considered a disease of the lungs secondary to cigarette smoking and characterized by airflow obstruction due to abnormalities of both airway (bronchitis) and lung parenchyma (emphysema). It is now well known that COPD is associated with significant systemic abnormalities, such as renal and hormonal abnormalities, malnutrition, muscle wasting, osteoporosis, and anemia. However, it is still unclear whether they represent consequences of the pulmonary disorder, or whether COPD should be considered as a systemic disease. These systemic abnormalities have been attributed to an increased level of systemic inflammation. Chronic inflammation, however, may not be the only cause of the systemic effects of COPD. Recent data from humans and animal models support the view that emphysema may be a vascular disease. Other studies have highlighted the role of repair failure, bone marrow abnormality, genetic and epigenetic factors, immunological disorders and infections as potential causes of COPD systemic manifestations. Based on this new evidence, it is reasonable to consider COPD, and emphysema in particular, as 'a disease with a significant systemic component' if not a 'systemic disease' per se. The aim of this review is to give an overview of the most relevant and innovative hypothesis about the extrapulmonary manifestations of COPD.
    MeSH term(s) Animals ; Disease Models, Animal ; Emphysema/physiopathology ; Humans ; Inflammation/etiology ; Inflammation/physiopathology ; Oxidative Stress ; Pulmonary Disease, Chronic Obstructive/complications ; Pulmonary Disease, Chronic Obstructive/physiopathology
    Language English
    Publishing date 2011-06
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2476459-0
    ISSN 1753-4666 ; 1753-4658
    ISSN (online) 1753-4666
    ISSN 1753-4658
    DOI 10.1177/1753465811400490
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top